Tiffany Thorn
Founder at BIVICTRIX THERAPEUTICS PLC
Net worth: 232 011 $ as of 2024-03-30
Profile
Tiffany Thorn is the founder and currently serves as the Chief Executive Officer & Executive Director of BiVictriX Therapeutics Plc, which is founded in 2016.
She previously served as the Chief Executive Officer & Director of Motif Bio Plc.
Ms. Thorn is a graduate of The University of Manchester and holds an undergraduate degree from the University of Lancaster.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-30 | 1,632,500 ( 1.98% ) | 232 011 $ | 2024-03-30 |
Tiffany Thorn active positions
| Companies | Position | Start |
|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Founder | 2015-12-31 |
Former positions of Tiffany Thorn
| Companies | Position | End |
|---|---|---|
| MOTIF BIO PLC | Chief Executive Officer | - |
Training of Tiffany Thorn
| The University of Manchester | Graduate Degree |
| University of Lancaster | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Tiffany Thorn
